Syncrosome is a specialized CRO that offers animal models and services for preclinical research. They focus on in vivo efficacy studies, particularly for diseases related to the central nervous system, cardiovascular system, metabolism, respiratory system, gastroenterology, and dermatology. They have expertise in CNS pharmacokinetics and bioavailability studies, with a special emphasis on the blood-brain barrier and neurotransmitter monitoring. Syncrosome has developed and validated more than 15 disease models in various therapeutic areas. They prioritize a proactive approach, appropriate study design, and relevant endpoints to provide clients with the most relevant data. Additionally, they place great importance on ethics, animal welfare, sustainable development, and the use of up-to-date techniques.